- cafead   Nov 12, 2024 at 09:03: PM
via Flagship Pioneering startup Vesalius Therapeutics has signed a deal with GSK, the companies announced Tuesday, for the British pharma to use its technology to find medicines for neurodegenerative disorders.
article source
article source